Index of 2006 Publications

 

  1. Gupta M, Sheppard BC, Corless CL, MacDonell KR, Blanke CD, Billingsley KG. Outcome following surgical therapy for gastrointestinal stromal tumors. J Gastrointest Surg. 2006 Sep-Oct;10(8):1099-105.
    PMID: 16966028
    PDF coming soon
  2. Heinrich, MC. Molecular basis for treatment of gastrointestinal stromal tumors. European Journal of Cancer Supplements
    Volume 4, Issue 3 , March 2006, Pages 10-18
    Link to ScienceDirect
    Download PDF
  3. Heinrich MC, Corless CL. Does tumor mutational status correlate with response to imatinib? Nat Clin Pract Oncol. 2006 Nov;3(11):600-1.
    PMID: 17080176
    Download PDF
  4. Corless CL, Harrell P, Lacouture M, Bainbridge T, Le C, Gatter K, White C Jr, Granter S, Heinrich MC. Allele-Specific Polymerase Chain Reaction for the Imatinib-Resistant KIT D816V and D816F Mutations in Mastocytosis and Acute Myelogenous Leukemia. J Mol Diagn. 2006 Nov;8(5):604-12.
    PMID: 17065430
    Download PDF
  5. Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, Baum CM, Casali PG. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet. 2006 Oct 14;368(9544):1329-38.
    PMID: 1704646
    Download PDF
  6. Heinrich MC, Corless CL, Blanke CD, Demetri GD, Joensuu H, Roberts PJ, Eisenberg BL, von Mehren M, Fletcher CD, Sandau K, McDougall K, Ou WB, Chen CJ, Fletcher JA. Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors. J Clin Oncol. 2006 Sep 5; (Epub ahead of print)
    PMID: 16954519
    Download PDF
  7. Schittenhelm MM, Yee KW, Tyner JW, McGreevey L, Haley AD, Town A, Griffith DJ, Bainbridge T, Braziel RM, O'farrell AM, Cherrington JM, Heinrich MC. FLT3 K663Q is a novel AML-associated oncogenic kinase: determination of biochemical properties and sensitivity to Sunitinib (SU11248). Leukemia. 2006 Sep 14; (Epub ahead of print)
    PMID: 16990784
    Download PDF
  8. De Angelo DJ, Stone RM, Heaney ML, Nimer SD, Paquette RL, Klisovic RB, Caligiuri MA, Cooper MR, Lecerf JM, Karol MD, Sheng S, Holford N, Curtin PT, Druker BJ, Heinrich MC. Phase I clinical results with tandutinib (MLN518), a novel FLT3 antagonist, in patients with acute myelogenous leukemia or high-risk myelodysplastic syndrome: safety, pharmacokinetics, and pharmacodynamics. Blood. 2006 Aug 15; [Epub ahead of print]
    PMID: 16902153
    Download PDF
  9. Lam MM, Corless CL, Goldblum JR, Heinrich MC, Downs-Kelly E, Rubin BP. Extragastrointestinal stromal tumors presenting as vulvovaginal/rectovaginal septal masses: a diagnostic pitfall. Int J Gynecol Pathol. 2006 Jul;25(3):288-92.
    PMID: 16810068
    Download PDF
  10. Walters DK, Mercher T, Gu TL, O'Hare T, Tyner JW, Loriaux M, Goss VL, Lee KA, Eide CA, Wong MJ, Stoffregen EP, McGreevey L, Nardone J, Moore SA, Crispino J, Boggon TJ, Heinrich MC, Deininger MW, Polakiewicz RD, Gilliland DG, Druker BJ. Activating alleles of JAK3 in acute megakaryoblastic leukemia. Cancer Cell. 2006 Jul;10(1):65-75.
    PMID: 16842366
    Download PDF
  11. Mehrany K, Swanson NA, Heinrich MC, Weenig RH, Lee KK, White CR Jr, Devere TS. Dermatofibrosarcoma protuberans: a partial response to imatinib therapy. Dermatol Surg. 2006 Mar;32(3):456-9.
    PMID: 16640697
    Download PDF
  12. Netto GJ, Watkins DL, Williams JW, Colby TV, dePetris G, Sharkey FE, Corless CL, Lewin D, Petrovic L, Sharma S, Kanel G, Theise N, West AB, Koehler A, Jhala NC, Lefkowitch J, Lezzoni J, Jennings LW, Tillery GW, Klintmalm GB; The Hepatitis C 3 Trial Group. Interobserver agreement in hepatitis C grading and staging and in the Banff grading schema for acute cellular rejection: the "hepatitis C 3" multi-institutional trial experience. Arch Pathol Lab Med. 2006 Aug;130(8): 1157-62.
    PMID: 16886238
  13. Seong CK, Pavcnik D, Uchida BT, Anai H, Timmermans H, Niyyati M, Corless CL, Correa LO, Keller FS, Rosch J. Experimental percutaneous extrahepatic portacaval shunt creation by transjugular approach in Swine. Cardiovasc Intervent Radiol. 2005 Sep-Oct;28(5):616-23.
    PMID: 16059763
  14. West RB, Rubin BP, Miller MA, Subramanian S, Kaygusuz G, Montgomery K, Zhu S, Marinelli RJ, De Luca A, Downs-Kelly E, Goldblum JR, Corless CL, Brown PO, Gilks CB, Nielsen TO, Huntsman D, Van de Rijn M. A landscape effect in tenosynovial giant cell tumor from activation of CSF1 expression by a translocation in a minority of tumor cells. Proc Natl Acad Sci 103:690-695, 2006.
    PMID: 16407111
    Download PDF
  15. Schittenhelm MM, Shiraga S, Schroeder A, Corbin AS, Griffith D, Lee FY, Bokemeyer C, Deininger MW, Druker BJ, Heinrich MC. Dasatinib (BMS-354825), a dual SRC/ABL kinase inhibitor, inhibits the kinase activity of wild-type, juxtamembrane, and activation loop mutant KIT isoforms associated with human malignancies. Cancer Res. 2006 Jan 1;66(1):473-81.
    PMID: 16505440
    Download PDF
  16. Sengupta S, Cheville JC, Corless CL, Lohse CM, Heinrich MC, Kwon ED, Zincke H, Blute ML, Leibovich BC. Rare expression of KIT and absence of KIT mutations in high grade renal cell carcinoma. J Urol. 2006 Jan;175(1):53-6.
    PMID: 16406868
    Download PDF
  17. Einhorn LH, Brames MJ, Heinrich MC, Corless CL, Madani A. Phase II study of imatinib mesylate in chemotherapy refractory germ cell tumors expressing KIT. Am J Clin Oncol. 2006 Feb;29(1):12-3.
    PMID: 16462496
    Download PDF
  18. Walters DK, Goss VL, Stoffregen EP, Gu TL, Lee K, Nardone J, McGreevey L, Heinrich MC, Deininger MW, Polakiewicz R, Druker BJ. Phosphoproteomic analysis of AML cell lines identifies leukemic oncogenes. Leuk Res. 2006 Feb 4; [Epub ahead of print].
    PMID: 16464493
    Download PDF
  19. Heinrich MC, McArthur GA, Demetri GD, Joensuu H, Bono P, Herrmann R, Hirte H, Cresta S, Koslin DB, Corless CL, Dirnhofer S, van Oosterom AT, Nikolova Z, Dimitrijevic S, Fletcher JA. Clinical and molecular studies of the effect of imatinib on advanced aggressive fibromatosis (desmoid tumor). J Clin Oncol. 2006 Mar 1;24(7):1195-203.
    PMID: 16505440
    Download PDF
  20. Goldman DC, Berg LK, Heinrich MC, Christian JL. Ectodermally derived steel/stem cell factor functions non-cell autonomously during primitive erythropoiesis in Xenopus. Blood. 2006 Apr 15;107(8):3114-21.
    PMID: 16357321
    Download PDF